MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer by Tingting Li et al.
RESEARCH Open Access
MicroRNA-224 sustains Wnt/β-catenin
signaling and promotes aggressive
phenotype of colorectal cancer
Tingting Li1,2,3†, Qiuhua Lai1,2,3†, Shuyang Wang1,2,3, Juanjuan Cai1,2,3, Zhiyuan Xiao1,2,3, Danling Deng1,2,3,
Liuqing He1,2,3, Hongli Jiao1,2,3, Yaping Ye1,2,3, Li Liang1,2,3, Yanqing Ding1,2,3 and Wenting Liao1,2,3*
Abstract
Background: Growing evidence suggests that Wnt/β-catenin pathway plays an important role in CRC development,
progression and metastasis. Aberrant miR-224 expression has been reported in CRC. However, the mechanism of
miR-224 promotes both proliferation and metastatic ability largely remains unclear.
Methods: Real-time PCR was used to quantify miR-224 expression. Luciferase reporter assays were conducted to
confirm the activity of Wnt/β-catenin pathway and target gene associations, and immunofluorescence staining
assay was performed to observe the nuclear translocation of β-catenin. Bioinformatics analysis combined with in
vivo and vitro functional assays showed the potential target genes, GSK3β and SFRP2, of miR-224. Specimens
from forty patients with CRC were analyzed for the expression of miR-224 and the relationship with GSK3β/SFRP2
by real-time PCR and western blot.
Results: Bioinformatics and cell luciferase function studies verified the direct regulation of miR-224 on the 3’-UTR
of the GSK3β and SFRP2 genes, which leads to the activation of Wnt/β-catenin signaling and the nuclear translocation of
β-catenin. In addition, knockdown of miR-224 significantly recovered the expression of GSK3β and SFRP2 and attenuated
Wnt/β-catenin-mediated cell metastasis and proliferation. The ectopic upregulation of miR-224 dramatically inhibited the
expression of GSK3β/SFRP2 and enhanced CRC proliferation and invasion.
Conclusion: Our research showed mechanistic links between miR-224 and Wnt/β-catenin in the pathogenesis of CRC
through modulation of GSK3β and SFRP2.
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Background
Human colorectal cancer (CRC) is one of the most com-
mon types of malignant tumor worldwide [1]. Although
several kinds of treatment modalities have been devel-
oped recently for the patients with CRC, the clinical out-
come of prognosis continues to be poor in patients with
advanced CRC. Metastasis is responsible for the majority
of cancer deaths. The aberrant activation of Wnt/β-ca-
tenin signaling pathway is considered to be an essential
issue in tumorigenesis and progression of CRC [2, 3].
The hallmark of the Wnt/β-catenin pathway is the ac-
cumulation and nuclear localization of β-catenin [4, 5].
Cytoplasmic β-catenin is controlled by the degradation
complex composed of adenomatosis polyposis coli
(APC), Axin, protein phosphatase 2A (PP2A), glycogen
synthase kinase 3 beta (GSK3β) and casein kinase 1α
(CK1α) [6–9]. When Wnt signaling is activated, β-
catenin is discharged from the degradation of complex
resulting in the translocation of β-catenin into nucleus,
where it associates with the T-cell factor/lymphoid en-
hancer factor (TCF/LEF) family of transcription factors
to activate specific Wnt target genes [10, 11]. It has
been well known that inactivating mutation of APC
gene has been considered to be an crucial event for
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constitutive activation of Wnt/β-catenin signaling mu-
tation which leads to carcinogenesis and progression in
CRC [12, 13]. However, it has been reported that the
mutation of APC cannot fully explain the reason of
colorectal tumor carcinogenesis [14, 15]. Thus, alterna-
tive mechanisms through which Wnt/β-catenin signal-
ing were activated in CRC might exist.
MicroRNAs (miRNAs) are a class of noncoding small
RNAs that play essential roles in the modulation of various
biological processes through directly binding to the 3’ un-
translated region (3’-UTR) of target genes, which resulting
in posttranscriptional inhibition and mRNA cleavage
[16, 17]. Accumulating evidence has indicated that dys-
regulation of miRNAs is closely related to the develop-
ment and progression of CRC [18, 19]. For example,
MicroRNA-30b can function as a tumor suppressor in
human colorectal cancer by targeting KRAS, PIK3CD
and BCL2 [20]. Also, our previous study has demon-
strated that miR-224 can promote cell proliferation by
repressing PHLPP1 and PHLPP2 in CRC [21].
In this study, we displayed the critical role of miR-224
in activating Wnt/β-catenin signaling pathway during
colorectal progression. We showed that promotion effect
of miR-224 on proliferation and invasion of human CRC
cells could be manifested partly through the accumulation
and nuclear translocation of β-catenin and subsequently
up-regulation of its transcriptional targets c-Myc [22, 23]
and CyclinD1 [24, 25]. Moreover, we demonstrated that
both of Wnt/β-catenin signaling pathway suppressors
GSK3β and SFRP2 are bona fide downstream targets of
miR-224.
Methods
Tissue specimens and cell cultures
The 40 freshly collected CRC specimens and their
matched adjacent peri-cancerous normal tissues and dis-
tantly metastasis tissues were collected at the operation
room, Nanfang Hospital. The fresh specimens were frozen
and stored in liquid nitrogen until further use. For the use
of clinical materials for research purposes, prior approval
was obtained from the Southern Medical University Insti-
tutional Board (Guangzhou, China). All samples were col-
lected and analyzed with the prior written, informed
consent of the patients.
Two human CRC lines SW480 and HCT116 were
purchased from American Type Culture Collection
Cell Biology Collection and were maintained in De-
partment of Pathology, Southern Medical University.
SW480 and HCT 116 cell lines were cultured in RPMI
1640 (Invitrogen, Carlsbad, CA, USA). All medium
was supplemented with 10 % FBS (PAA Laboratories,
Pasching, Austria) and 1 % penicillin/streptomycin
(Invitrogen) at 37 °C with 5 % CO2.
RNA isolation, reverse transcription (RT) and real-time PCR
Total RNA from cultured cells and fresh surgical CRC tis-
sues was isolated using the mirVana miRNA Isolation Kit
(Ambion) according to the manufacturer’s instruction. The
cDNA was then synthesized from total RNA using the Taq-
man miRNA reverse transcription kit (Applied Biosystems,
Foster City, CA, USA). Real-time PCR was performed with
the Applied Biosystems 7500 Sequence Detection system,
using iQ™ SYBR Green Supermix (BioRad Laboratories,
Hercules, CA, USA) containing 5 ng cDNA and 10 pM of
each primer. The cycling conditions were set as previously
described [20]. The data were normalized to the geometric
mean of housekeeping gene GAPDH or U6 small nuclear
RNA expression and calculated as 2−ΔΔCT method. Primers
for real-time PCR were designed using Primer Premier 5
software. Sequences of the primers are summarized in
Additional file 1: Table S1.
Plasmids and transfection
To generate a miR-224 expression vector, a 281 bp gen-
omic fragment covering the region coding for pri-miR-
224 and its upstream and downstream regions was PCR
amplified and cloned into the pLvthm vector (Addgene).
The fulllength of GSK3β 3’-UTR is 4849 bp long and the
SFRP2 3’-UTR is 876 bp long. The miR-224 binding site
in the GSK3β 3’-UTR is located at 4755 to 4762 bp, and
316 to 323 bp in the SFRP2 3’-UTR. The region of the
human GSK3β 3’-UTR from 4635 to 4825 bp and SFRP2
3’-UTR from 209 to 549 bp were generated by PCR
amplification and subcloned into the MluI/NheI sites of
the pGL3-basic luciferase reporter plasmid (Promega).
The miR-224 mimics, negative control and anti-miR-224
inhibitors were purchased from Genecopoeia (Geneco-
poeia Co. Ltd.) and transfected into CRC cells using Li-
pofectamine 2000 reagent (Invitrogen), according to the
manufacturer’s instructions. Two concentrations of miR-
224 mimics or anti-miR-224 inhibitors (20 and 50 nM)
were applied. Also, the CDS of GSK3β was generated by
PCR amplification and subcloned into the NheI/EcoRI
sites of the pSin-EF2-puro plasmid, and the CDS of
SFRP2 was generated by PCR amplification and sub-
cloned into the SpeI/EcoRI sites of the pSin-EF2-puro
plasmid. The primers used to generate above constructs
are listed in Additional file 2: Table S2. The stable cell
lines were established as previously described [26].
Western blotting
We performed western blot according to the previous
study [21]. Protein lysates were prepared, subjected to
SDS-PAGE, transferred onto PVDF membranes and blot-
ted according to standard methods, using anti-GSK3β,
anti-phospho-β-catenin (Ser9), (Cell Signaling Technol-
ogy), anti-CyclinD1, anti-c-Myc (Bioworld Technology, St.
Louis Park, MN, USA)), anti-Ki-67 (Abcam, Cambridge,
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MA, USA), anti-MMP7, anti-SFRP2 (BD Biosciences, San
Diego, CA, USA), anti-β-catenin (BD Biosciences, San
Diego, CA, USA). Anti-α-Tubulin monoclonal antibody
(Sigma, St Louis, MO, USA) served as a loading control.
Luciferase assays
Cells (8 × 104) were seeded in triplicate in 24-well plates
and allowed to settle for 24 h. Luciferase reporter plasmids
(100 ng) or 100 ng control luciferase plasmid plus 1 ng
pRL-TK Renilla plasmid (Promega) were transfected into
colorectal cancer cells using Lipofectamine 2000 (Invitro-
gen). Luciferase and Renilla signals were determined 24 h
after transfection using a Dual Luciferase Reporter Assay
Kit (Promega) [27, 28].
Soft-agar colony formation assay, three-dimensional
morphogenesis assay, transwell assay and
immunohistochemistry
The miR-224 mimics, anti-miR-224 inhibitors, negative
control oligos and GSK3β/SFRP2 plasmids were transi-
ently transfected into CRC cells for the soft agar colony-
formation assay, three-dimensional morphogenesis assay,
transwell assay and immunohistochemistry, as previously
described [21, 29].
Xenograft model in nude mice
For tumourigenesis assays, Xenograft tumors were gen-
erated by subcutaneous injection of stable cell lines. Ani-
mal experiments were conducted as previously described
[20]. Details are as previously Supplementary Materials
and Methods described [21]. All mice were obtained
from the Animal Center of Southern Medical University,
Guangzhou, China, and housed and maintained under
specific pathogen-free conditions, and all experiments
were approved by the Use Committee for Animal Care and
performed in accordance with institutional guidelines.
Tumor size was measured using a slide caliper and tumor
volume was determined by the formula: 0.44 ×A × B2,
where A represents the diameter of the base of the tumor
and B represents the corresponding perpendicular value.
Statistical analysis
All experiments were performed at least twice. Results
are expressed as mean ± S.E.M. where applicable. The
two-tailed Student’s t-test was used to compare the in-
tergroup. Spearman’s correlation analyses were used to
analyze the relationship between miR-224 expression
and target genes. Differences between groups were con-
sidered statistically significant at p < 0.05. Analyses were
done with SPSS 19.0 software (IBM, Armonk, NY, USA).
Results
MiR-224 activates the Wnt/β-catenin signaling in CRC cells
Previously, we found that miR-224 could promote cell
proliferation by repressing PHLPP1 and PHLPP2 in CRC.
Besides the activation of AKT signaling, we also observed
that miR-224 can activated Wnt/β-catenin signaling. The
activity of Wnt/β-catenin signaling pathway by TOP/FOP
Luciferase assay was significantly increased in miR-
224-overexpressing CRC cells and reduced in miR-224-
inhibited CRC cells (Fig. 1a). Further, we carried out
Western blot and real-time PCR to analyze the transcrip-
tional downstream genes of Wnt/β-catenin signaling.
Figure 1b and c showed that overexpression of miR-224
significantly upregulated c-Myc, CyclinD1, MMP7 and the
activity of β-catenin, while inhibition of miR-224 obviously
downregualted c-Myc, CyclinD1, MMP7 and the activity
of β-catenin. Moreover, immunofluorescence staining
assay displayed that overexpression of miR-224 could evi-
dently promote the nuclear localization of β-catenin
(Fig. 1d).
MiR-224 directly targets GSK3β and SFRP2
In order to predict the putative miR-224 target genes, tar-
get prediction program (TargetScan) was applied. The re-
sults revealed that GSK3β and SFRP2 are two potential
targets of miR-224. The 3’-UTR of GSK3β and SFRP2
mRNA contains a complementary site for the seed region
of miR-224 (Fig. 2a). It has been reported that GSK3β and
SFRP2 are key regulators of Wnt signaling by controlling
the activity of the β-catenin/TCF transcription complex.
Real-time PCR (Fig. 2b) and western blot (Fig. 2c) results
showed that both the mRNA and protein levels of both
GSK3β and SFRP2 were significantly downregulated in
miR-224-overexpressing cells, whereas GSK3β and SFRP2
were upregulated after inhibition of miR-224 in CRC cells.
Furthermore, we subcloned the wild-type and mutant
fragments of GSK3β or SFRP2 3’-UTR fragment separ-
ately into the pGL3-basic luciferase reporter vectors. As
showed in Fig. 2d, both wild-type GSK3β and SFRP2
reporter gene luciferase activity was reduced upon overex-
pression of miR-224 in both colorectal cancer cell lines,
whereas inhibition of miR-224 increased wild-type GSK3β
or SFRP2 luciferase activity.
MiR-224 promote migration and proliferation of CRC cells
partly through inhibition of GSK3β and SFRP2 in vitro
GSK3β and SFRP2 are important effectors of numerous
miRNAs in human cancers, so we need to further ex-
plore the biological effects of miR-224 on GSK3β and
SFRP2 in a reverse logic. We adopted western blot assay
to detected the role of miR-224 in CRC cells under over-
expression of GSK3β and SFRP2 (Fig. 3a). Cell function
assays displayed that upregulation of miR-224 revealed
higher proliferation, migration and invasion capacity,
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Fig. 1 MiR-224 activates the Wnt/β-catenin signaling and results in subsequent β-catenin relocation. a TOP/FOP Luciferase assay revealed that the
activity of Wnt/β-catenin signaling pathway positively correlated with miR-224 expression. b Western blot analysis of crucial downstream molecules
and (c) real-time PCR analysis of crucial downstream molecules. d β-catenin expression was assessed by immunofluorescence staining in both cell lines
treated with the negative control miRNA or miR-224 mimics or miR-224 inhibitors for 48 h. β-catenin is shown in red, and the nuclei are counterstained
with DAPI that are shown in blue. Scale bars = 10 μm. Error bars represent mean ± SD from 3 independent experiments; * p < 0.05, ** p < 0.01
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while ectopic up-regulated GSK3β and SFRP2 could par-
tially reverse the influence of miR-224 on CRC cells
growth, migration and invasion. Soft agar assays displayed
that inhibition of miR-224 evidently reduced the growth
rate of both colorectal cancer cell lines while overexpres-
sion of miR-224 promoted the growth rate of both colo-
rectal cancer cell lines (Fig. 3b). Impact of miR-224 on cell
migration (Fig. 3c) and invasion (Fig. 3d) across a Trans-
well chamber and three-dimensional morphogenesis assay
(Fig. 3e) showed that inhibition of miR-224 supressed mi-
gration and invasion capacity of both colorectal cancer
cell lines, while overexpression of miR-224 enhanced mi-
gration and invasion capacity of both colorectal cancer
cell lines. Especially, compared with other cells, overex-
pression of miR-224 displayed a long spindle-shaped form
with thin, long pseudopods, which occasionally resembled
finger-like pseudopods that extended from the cell bod-
ies (Fig. 3e). In addition, the results showed ectopic
overexprssion of GSK3β and SFRP2 could partially re-
verse the influence of miR-224 on cell growth migration
and invasion.
GSK3β and SFRP2 are the bona fide effector of miR-224
in vivo
To understand whether GSK3β and SFRP2 are involved in
miR-224 mediated CRC tumorgenesis in vivo, we engi-
neered SW480 cells to stably overexpress miR-224. The
control cells, miR-224-overexpressing cells and the re-
stored GSK3β and SFRP2 in miR-224-overexpressing cells
were subcutaneously inoculated into nude mice separately.
As shown in Fig. 4a and b, the tumors in the SW480/miR-
224 group grew more rapidly than the other group tu-
mors, SW480/NC group and SW480/miR-224-GSK3β
-SFRP2 group (P < 0.01). IHC staining (Fig. 4c/d) further
confirmed that the tumors of the miR-224-overexpressing
group displayed much higher Ki-67 indexes than the other
two groups.
Clinical data confirmed GSK3β or SFRP2 are the direct
targets of miR-224
To further verify the above observations, miR-224 directly
targets GSK3β and SFRP2, could be supported by observa-
tions in human CRC. We first tested the expression of
Fig. 2 MiR-224 could target GSK3β and SFRP2 in CRC. a Predicted miR-224 target sequences in the 3’-UTRs of GSK3β or SFRP2, and their mutants
containing altered nucleotides in the 3’-UTRs. b Real-time PCR analysis of GSK3β or SFRP2. c Western blot analysis of GSK3β or SFRP2. d Luciferase
assay analyses of the indicated cells transfected with the indicated reporters with increasing amounts of miR-224 (20 and 50 nM). Error bars represent
mean ± SD from three independent experiments; * p < 0.05, ** p < 0.01
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Fig. 3 (See legend on next page.)
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Fig. 4 GSK3β and SFRP2 are the bona fide effector of miR-224 in vivo. a Tumor xenograft model. Cells were injected into the hindlimbs of nude
mice (n = 6). Representative images of the tumors are shown. b Tumor volumes were measured on the indicated days. Data points are presented
as the mean tumor volume ± SD. c Histopathology of xenograft tumors. The tumor sections were under H&E staining and IHC staining using
antibody against Ki-67. d The percentage of Ki67 positive cells. Error bars represent mean ± SD from 3 independent experiments; * p < 0.05,
** p < 0.01
(See figure on previous page.)
Fig. 3 MiR-224 manipulates the colon cancer cells proliferation and migration partly through GSK3β and SFRP2. a Western blot analysis of GSK3β or
SFRP2. b Soft agar assay. Representative micrographs are shown (left) and only cell colonies > 0.1 mm in diameter were counted (right). c Representative
images (left) and quantification (right) of migrated cells across a Transwell chamber. d Representative images (left) and quantification (right) of invaded
cells across a Transwell chamber. e Representative micrographs of indicated cultured cells at day 7 of culture in three-dimensional morphogenesis assay.
Error bars represent mean ± SD from 3 independent experiments; *p< 0.05, ** p< 0.01
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Fig. 5 (See legend on next page.)
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miR-224 by real-time PCR analysis in 20 pairs of distant
metastasis (liver, DM), CRC primary tumor (PT), and
peri-cancerous normal tissues (NT). The results (Fig. 5a
and b) revealed that miR-224 was significantly overex-
pressed in DM and PT tissues than NT tissues (p < 0.01).
Moreover, the expression levels of miR-224 were higher in
DM than in PT tissues (p < 0.01). Then we analyzed 20
pairs of freshly CRC tissues and normal tissues to explore
the relationship between miR-224 and GSK3β or SFRP2.
Figure 5c revealed that miR-224 was up-regulated in CRC
tissues while GSK3β or SFRP2 were down-regulated in
CRC tissues. The 20 pairs Q-PCR data was attached in
Additional file 3: Data S1. Spearman correlation analyses
shows that miR-224 expression negatively correlated
with the expressions of GSK3β (r = –0.761, p < 0.01),
SFRP2 (r = –0.749, p < 0.01) (Fig. 5d). Also, western blot
analysis confirmed miR-224 expression negatively cor-
related with the expressions of GSK3β and SFRP2
(Fig. 5e). The above molecular link provides a signifi-
cant clue for us to figure out the role of miR-224 in the
process of CRC Wnt/β-catenin signaling.
Discussion
MiRNAs are endogenous non-coding RNAs that are re-
lated to several key biological processes of tumor, such as
tumor initiation, cell proliferation and metastasis which
decrease gene expression through binding to the 3’-UTR
of target mRNAs [18, 30, 31]. The Wnt/β-catenin signal-
ing pathway has been recognized to play a critical role in
regulating oncogenesis and metastasis [17, 32, 33]. Nota-
blely, many evidence approved aberrant activation of
Wnt/β-catenin signaling is a hallmark of colorectal
tumorigenesis as well as in later stages of invasion and
metastasis [2, 18, 34]. Meanwhile, accumulated evidence
showed that miRNAs are crucial modulators of Wnt/β-ca-
tenin signaling pathway [35–38]. In addition, recent stud-
ies demonstrated that miR-224 can promote cell invasion
and proliferation in several human cancers [39–41], espe-
cially in CRC [21, 42], suggesting its function as an onco-
gene. However, no further explanations were carried out
to illuminate the relationship between miR-224 and Wnt/
β-catenin signaling and the mechanism of miR-224-
induced CRC invasion. In this study, we demonstrated the
role of miR-224 in activating Wnt/β-catenin signaling,
and caused the malignant of CRC.
To explore the impact of miR-224 on Wnt/β-catenin sig-
naling pathway, we tested the activity of Wnt/β-catenin
signaling pathway by performing TOP/FOP Luciferase
assays. The T cell factor (TCF) activity was significantly
increased in miR-224 -overexpressing CRC cells, but was
decreased in miR-224-inhibited cells. Furthermore, down-
stream molecules of Wnt signaling and the activity of β-
catenin were significantly positive correlated with miR-224.
Furthermore, the results demonstrate that miR-224 could
promote β-catenin translocate into nucleus.
To further clarify the functional mechanism by which
miR-224 activates the Wnt/β-catenin signaling cascade.
By bioinformatics prediction (TargetScan) and functional
analysis, we identified GSK3β and SFRP2 as direct down-
stream targets of miR-224. As a crucial member of Wnt/
β-catenin signaling modulators, GSK3β plays a central
role in the degradation complex and directly depends on
the phosphorylation level of β-catenin [43]. GSK3β knock-
down promotes several kinds of cancer proliferation and
metastasis by promoting β-catenin translocation into nu-
cleus and upregulated oncogene snail expression to pro-
mote cancer cells metastasis [44, 45]. SFRP2 is a newly
discovered Wnt signaling negative modulators by direct
interaction with Wnts [46, 47]. SFRP2 is also downregu-
lated in colorectal cancer and is linked with the EMT as
well as proliferation [48, 49]. Collectively, these studies
suggest that restoration of the expression or function of
the GSK3β and SFRP2 may represent a potential novel
therapeutic intervention strategy for CRC. However, pre-
cise details of the mechanisms which regulate GSK3β and
SFRP2 need further investigation.
Our results confirmed that both GSK3β and SFRP2
were direct targets of miR-224. More specifically, we
found that miR-224 significantly downregulated the ex-
pression of GSK3β and SFRP2 in CRC cells. Furthermore,
we found that GSK3β and SFRP2 restoration could re-
verse the biological ability of enforced miR-224 expression
in vitro and in xenograft models. Interestingly, we found
that the miR-224 expression in distantly metastasis tissues
was higher than primer tumor tissues and normal tissues
by analysis of 20 pairs of clinical tissues. Finally, expres-
sion analyses of miR-224, GSK3β and SFRP2 in 20 clinical
colorectal cancer tissues revealed significant negative cor-
relations between miR-224 and the expression of GSK3β
and SFRP2. All these results supported that miR-224
(See figure on previous page.)
Fig. 5 Clinical data confirmed GSK3β or SFRP2 are the direct targets of miR-224. a Real-time PCR analysis of miR-224 expression in 20 pairs of
peri-cancerous normal tissues (NT), CRC primary tumor tissues (PT), and distantly metastasis tissues (liver, DM); miR-224 expression was normalized
to U6. b Mean expression of miR-224 in the 20 pairs of peri-cancerous normal tissues (NT), CRC primary tumor (PT), and distantly metastasis (DM).
c Real-time PCR analysis of miR-224, GSK3β and SFRP2 expression and (d) Spearman correlation analyses between relative miR-224 expression
and relative mRNA expression levels of GSK3β and SFRP2 in 20 fresh human CRC samples. e Western blot analysis of GSK3β and SFRP2 in the 20
fresh human CRC samples; α-Tubulin was used as loading control (lower panel). Error bars represent mean ± SD from 3 independent experiments;
* p < 0.05, ** p < 0.01
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promoted cell metastasis and proliferation through the
Wnt/β-catenin pathway.
Conclusions
In summary, this study demonstrates meaningful evidence
expounding a new functional role of miR-224 in CRC. We
showed that miR-224 has the ability to promote CRC cell
growth and invasion, which are the basal behavior in CRC
metastasis, through directly activating Wnt/β-catenin
signaling by targeting GSK3β and SFRP2. Also, restoring
the expression of GSK3β and SFRP2 restrained miR-224-
induced aggressive phenotype of colorectal cancer cells.
Furthermore, miR-224 expression is upregulated in colorec-
tal cancer tumor samples and is inversely correlated with
GSK3β and SFRP2. Our results discovered a new role of
miR-224, modulating Wnt/β-catenin signaling in CRC
tumorgenesis, further indicating that miR-224 may serve as
a diagnostic and prognostic biomarker for colorectal cancer.
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